More than 3,000 people in England were affected by Strep A between September 2022 and May 2023
News
Study reveals heart failure device could monitor patients and prevent hospitalisation
Heart failure is a cardiovascular disease that affects more than 64 million people worldwide
MIT’s new MRI brain light-detecting technique could support brain cell studies
Bioluminescence used MRI to observe the dilation of luciferase in engineered blood vessels
PharmaTimes MSEA and NIEA awards are open for entry
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024
BBSRC invests £48m in Babraham Institute to advance lifelong health research
The funding will help to support research across epigenetics, immunology and cell signalling
NHS reduces long waits for cancer care and achieves faster ambulance responses
For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer
MHRA’s AI Airlock to address challenges for regulating AI medical devices
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
Oregon and Lantern collaborate to develop drug candidate for various cancer indications
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
OneChain’s CAR T trial treats its first cortical T-cell ALL patient
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
The findings could potentially lead to new therapies and could stop the growth of cancers
Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
NHS to roll out fibre optic laser therapy to prevent seizures in epileptic patients
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
Francis Crick Institute and Broken String Biosciences partner for ALS research
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Cambridge researchers develop robotic nerve devices for neurological conditions
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide
International phase 3 clinical trial for new melanoma treatment recruits first patients
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
